| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9433d6f84bf5dea23b788db83010e650
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d83706643c618348b3655235176dda0 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 |
| filingDate |
2004-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1bedada62c5b037aa32200f0110c7fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e15609d6c3eecf41b623e2406476290 |
| publicationDate |
2006-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
UA-74922-C2 |
| titleOfInvention |
Drug for adjuvant therapy of malignant tumors |
| abstract |
The invention relates to the medicine, in particular to oncology and may be used for the adjuvant therapy of the malignant tumors. The drug contains the complex compound of calcium aldonate and ethylenediamine disuccinate taken at equimolar ratio. |
| priorityDate |
2004-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |